This Article Full Text (PDF) All Versions of this Article: 0269881106069637v1 21/4/405    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Cooper, G.D. Articles by Goudie, A.J. Search for Related Content PubMed PubMed Citation Articles by Cooper, G.D. Articles by Goudie, A.J. Social Bookmarking                   What's this?

Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities

School of Psychology, University of Liverpool, Liverpool, UK

L.C. Pickavance

Department of Veterinary Preclinical Science, University of Liverpool, Liverpool, UK

J.P.H. Wilding

School of Clinical Sciences, Division of Metabolic and Cellular Medicine, University of Liverpool, Liverpool, UK

J.A. HarroLd

School of Psychology, University of Liverpool, Liverpool, UK

J.C.G. HaLford

School of Psychology, University of Liverpool, Liverpool, UK

A.J. Goudie

School of Psychology, University of Liverpool, Liverpool, UK, , ajg{at}Liverpool.ac.uk

Many of olanzapine's (OLZ) actions in humans related to weight regulation can be modelled in female rats (Cooper et al., 2005). Such effects include weight gain, hyperphagia, enhanced visceral adiposity and elevated Levels of insulin and adiponectin. As sex differences have been reported in the effects of antipsychotic drugs, including OLZ, in rats, the current study extended our study in female rats by directly comparing the actions of OLZ in maLes using identical methodology. Individually housed male Han Wistar rats were administered OLZ twice daily (i.p.), at 0, 1, 2, and 4 mg/kg over 21 days. Both differences from, and simiLarities to, the data obtained in females were obtained. Males treated with OLZ showed reduced weight gain, enhanced visceral adiposity and reduced Lean muscle mass. There were no accompanying changes in food or water intake. OLZ did not induce changes in plasma Levels of insulin, Leptin or gLucose. Significant elevation of adiponectin was observed. OLZ-treated males dispLayed elevated prolactin and suppressed testosterone. OLZ's effects in humans can very clearly be most validly modelled in female rats, although the cause(s) of the sex difference in OLZ's actions in rats are not clear. However, the finding that significantly enhanced adiposity is seen in both male and female rats, in other animal species (mice and dogs) and in humans suggests that studies in male rats of OLZ's effects may be of value, by highlighting the consistent ability of OLZ to increase visceral adiposity. It is hypothesized that such adiposity is a key, clinically relevant, common component of OLZ's actions which may be, at Least partially, independent of both OLZinduced weight gain and hyperphagia, and which is induced reliably in male and female rats and other animal species. Possible mechanisms involved in the effects reported are discussed.

Key Words: olanzapine • weight gain • hyperphagia • adiposity • adiponectin • rat

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Coccurello, A. Caprioli, R. Conti, O. Ghirardi, F. Borsini, P. Carminati, and A. Moles Olanzapine (LY170053, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] Benzodiazepine), but Not the Novel Atypical Antipsychotic ST2472 (9-Piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), Chronic Administration Induces Weight Gain, Hyperphagia, and Metabolic Dysregulation in Mice J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 905 - 911. [Abstract] [Full Text] [PDF]

				M. V. Seeman Secondary Effects of Antipsychotics: Women at Greater Risk Than Men Schizophr Bull, April 9, 2008; (2008) sbn023v1. [Abstract] [Full Text] [PDF]